#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Sean Ianchulev Email
CEO And President . Eyenovia
How to contact Sean Ianchulev
Join and see Sean's contact info for free!Current Roles
Employees:
68Revenue:
$10.5MAbout
Eyenovia, Inc. (NASDAQ: EYEN) is a specialty biopharmaceutical company building a portfolio of next generation topical eye treatments based on its proprietary delivery and formulation platform for microdosing. Eyenoviaￃﾢ￢ﾂﾬ￢ﾄﾢs pipeline is currently focused on the late-stage development of microdosed medications for myopia progression, glaucoma, mydriasis and other eye diseases.Eyenovia Address
New York, NY
United States